Mark G. Foletta - Jun 17, 2024 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: /s/ Jereme M Sylvain For: Mark G Foletta
Stock symbol
DXCM
Transactions as of
Jun 17, 2024
Transactions value $
-$702,029
Form type
4
Date filed
6/20/2024, 04:50 PM
Previous filing
May 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$806 -7 -0.01% $115.18 62.4K Jun 17, 2024 by Trust F1, F2
transaction DXCM Common Stock Sale -$259K -2.21K -3.55% $117.16 60.2K Jun 17, 2024 by Trust F1, F2, F3
transaction DXCM Common Stock Sale -$55.9K -475 -0.79% $117.77 59.7K Jun 17, 2024 by Trust F1, F2, F4
transaction DXCM Common Stock Sale -$351K -3.01K -5.04% $116.75 56.7K Jun 18, 2024 by Trust F1, F2, F5
transaction DXCM Common Stock Sale -$35.1K -299 -0.53% $117.25 56.4K Jun 18, 2024 by Trust F1, F2, F6
holding DXCM Common Stock 2.97K Jun 17, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On March 15, 2024, the Foletta Family Trust DTD 1/30/15 (the ?Trust?) adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.
F3 This transaction was executed in multiple trades at prices ranging from $116.76 to $117.60. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 This transaction was executed in multiple trades at prices ranging from $117.61 to $117.83. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 This transaction was executed in multiple trades at prices ranging from $116.265 to $117.195. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F6 This transaction was executed in multiple trades at prices ranging from $117.235 to $117.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.